Heart failure & cardiomyopathiesResearch article

The ALT FLOW early feasibility study 3-year results assessing left atrial to coronary sinus shunting in HFpEF

ESC Heart FailPublished

  • Early Feasibility Study

Authors' conclusion

In patients with HF and LVEF >40%, the APTURE LA-to-CS shunting confirmed an acceptable safety profile with stable right heart parameters and sustained improvements in symptoms, quality of life, and functional capacity at 3 years. Observed survival and HFH were superior to MAGGIC predictions.

Study context

Population
Patients with heart failure and left ventricular ejection fraction (LVEF) > 40% treated with left atrial-to-coronary sinus (LA-to-CS) shunting through the APTURE transcatheter shunt systempatients with LVEF > 40%
Participants
95 patients
Comparison
MAGGIC score predicted 3-year all-cause mortality was compared with observed mortality assessed by Kaplan-Meier analysis using adjudicated events

Main finding

As reported in the abstract

Safety profile and shunt patency · 3 years
  • Safety profile remained stable with no new safety signals
  • All implanted shunts remained patent

Further findings

HFH-free survival · 3 years · observed HFH-free survival higher

P < 0001

OutcomeObservedMAGGIC-predictedP value
3-year survival · observed survival significantly higher84.4%70.2P & .009

NYHA class improvement by at least one class · 3 years

Patients improved by at least one NYHA class
76.3%

KCCQ Overall Summary Score change from baseline · 3 years

Mean increase from baseline
25 points
P
P < 0.0001

6-min walk distance change · 3 years

Average improvement
39 m
P
P & .002
  • These benefits were consistent regardless of baseline pulmonary vascular resistance (PVR)

Right heart echocardiographic parameters · 3 years

Right heart echocardiographic parameters stable
Reduction in TAPSE observed, primarily in the high PVR subgroup

Original publication

The ALT FLOW early feasibility study 3-year results assessing left atrial to coronary sinus shunting in HFpEF. ESC Heart Fail. Published 12 March 2026. doi:10.1093/eschf/xvag070

Summarised from the published abstract; every number is checked against it